This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2007;46(16):1313-5.

doi: 10.2169/internalmedicine.46.1914. Epub 2007 Aug 15.

Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases

Yoshiya Tanaka¹

Affiliations

Affiliation

¹ The First Department of Internal Medicine, School of Medicine, University of Occupational & Environmental Health, Japan. tanaka@med.uoeh-u.ac.jp <tanaka@med.uoeh-u.ac.jp>

PMID: 17704614
DOI: 10.2169/internalmedicine.46.1914

Free article

Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases

Yoshiya Tanaka. Intern Med. 2007.

Free article

. 2007;46(16):1313-5.

doi: 10.2169/internalmedicine.46.1914. Epub 2007 Aug 15.

Author

Yoshiya Tanaka¹

Affiliation

¹ The First Department of Internal Medicine, School of Medicine, University of Occupational & Environmental Health, Japan. tanaka@med.uoeh-u.ac.jp <tanaka@med.uoeh-u.ac.jp>

PMID: 17704614
DOI: 10.2169/internalmedicine.46.1914

No abstract available

PubMed Disclaimer

Similar articles

[Anti-CD20 antibody therapy for inflammatory immune diseases].
Tanaka Y. Tanaka Y. Nihon Naika Gakkai Zasshi. 2006 Sep 10;95(9):1801-6. doi: 10.2169/naika.95.1801. Nihon Naika Gakkai Zasshi. 2006. PMID: 17037318 Review. Japanese. No abstract available.
[B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
Tanaka Y. Tanaka Y. Yakugaku Zasshi. 2009 Jun;129(6):675-9. doi: 10.1248/yakushi.129.675. Yakugaku Zasshi. 2009. PMID: 19483410 Review. Japanese.
B-cell depletion and repopulation in autoimmune diseases.
Pers JO, Daridon C, Bendaoud B, Devauchelle V, Berthou C, Saraux A, Youinou P. Pers JO, et al. Clin Rev Allergy Immunol. 2008 Feb;34(1):50-5. doi: 10.1007/s12016-007-8015-4. Clin Rev Allergy Immunol. 2008. PMID: 18270858 Review.
Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
Goldblatt F, Isenberg DA. Goldblatt F, et al. Handb Exp Pharmacol. 2008;(181):163-81. doi: 10.1007/978-3-540-73259-4_8. Handb Exp Pharmacol. 2008. PMID: 18071946 Review.
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
Pescovitz MD. Pescovitz MD. Am J Transplant. 2006 May;6(5 Pt 1):859-66. doi: 10.1111/j.1600-6143.2006.01288.x. Am J Transplant. 2006. PMID: 16611321 Review.

See all similar articles

Cited by

Exploring the role of immunotherapeutic drugs in autoimmune diseases: A comprehensive review.
Patil S, Gs V, Sarode GS, Sarode SC, Khurayzi TA, Mohamed Beshir SE, Gadbail AR, Gondivkar S. Patil S, et al. J Oral Biol Craniofac Res. 2021 Apr-Jun;11(2):291-296. doi: 10.1016/j.jobcr.2021.02.009. Epub 2021 Feb 23. J Oral Biol Craniofac Res. 2021. PMID: 33948430 Free PMC article. Review.
B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis.
Tuscano JM, Sands J. Tuscano JM, et al. Biologics. 2009;3:225-32. doi: 10.2147/btt.2009.3126. Epub 2009 Jul 13. Biologics. 2009. PMID: 19707411 Free PMC article.
Long-term Successful Treatment of Rituximab for Steroid-resistant Minimal Change Nephrotic Syndrome and Idiopathic Thrombocytopenic Purpura.
Nishikawa M, Shimada N, Kawazoe T, Sawaki R, Ikuta H, Kanzaki M, Fukuoka K, Fukushima M, Asano K. Nishikawa M, et al. Intern Med. 2020 Apr 1;59(7):983-986. doi: 10.2169/internalmedicine.3837-19. Epub 2019 Dec 20. Intern Med. 2020. PMID: 31866629 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- J-STAGE, Japan Science and Technology Information Aggregator, Electronic
Medical
- MedlinePlus Health Information